quinuclidines has been researched along with Urinary Incontinence in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 35 (71.43) | 29.6817 |
2010's | 14 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, P; Hart, WM; Munro, V; Nazir, J; Retsa, P | 1 |
Ahlering, TE; Liss, MA; Morales, B; Skarecky, D | 1 |
Chen, Y; Liu, B; Liu, Z; Mo, Q; Wang, Y; Wu, J; Xu, H | 1 |
Ahlering, TE; Albala, DM; Belkoff, LH; Bianco, FJ; Bradt, JS; Haas, GP; He, W; Miles, BJ; Peabody, JO | 1 |
Dmochowski, R | 1 |
Ahn, H; Choi, SK; Choo, MS; Huh, KO; Kim, J; Lee, SM; Park, S; Shim, M; Song, C | 1 |
Choo, MS; Jung, HC; Kim, HJ; Kim, JC; Kim, YH; Lee, JB; Lee, JG; Lee, JZ; Lee, KS; Na, YG; Paick, JS; Seo, JT | 1 |
Iannazzo, S; Pradelli, L | 1 |
Doroshyenko, O; Fuhr, U | 1 |
Andoh, M; Appell, RA; Fakhoury, A; Hussain, IF; Ostergard, DR; Toglia, MR | 1 |
Bolduc, S; Hamel, M; Lamontagne, P; Lebel, S; Moore, K; Nadeau, G | 1 |
Chernev, T; Dimitrov, R; Doganov, N; Popov, E; Slavov, Ch; Slavov, S | 1 |
Chang, TC; Ho, CH; Huang, KH; Lin, HH; Liu, SP; Yu, HJ | 1 |
Cody, JD; Ellis, G; Hay-Smith, EJ; Herbison, GP; Madhuvrata, P | 1 |
Kane, RL; Ramakrishnan, R; Sainfort, F; Shamliyan, T; Wyman, JF | 1 |
Alessandri, F; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Origoni, M; Remorgida, V; Salvatore, S; Venturini, PL | 1 |
Ammann, LP; Bukofzer, S; Haas, GP; He, W; Janning, SW; Zinner, NR | 1 |
Cardozo, L; Robinson, D | 2 |
Hsieh, M; Kershen, RT | 1 |
Cardozo, L; Drogendijk, TE; Huang, M; Kuzmin, I; Lisec, M; Millard, R; Ridder, AM; van Vierssen Trip, O | 1 |
Sand, PK | 1 |
Cardozo, L; Chapple, CR; Haab, F; Kelleher, CJ; Ridder, AM | 1 |
Cardozo, L; Chapple, C; Haab, F; Ridder, AM | 1 |
Bolodeoku, J; Chapple, CR; Drogendijk, T; Martinez-Garcia, R; Selvaggi, L; Toozs-Hobson, P; Warnack, W; Wright, DM | 1 |
Abrams, P; Swift, S | 1 |
Oehlke, KJ | 1 |
Ikeda, K; Naito, R; Okamoto, Y; Takeuchi, M; Toyoshima, A; Yonetoku, Y | 1 |
Dmochowski, RR; Staskin, DR; Wein, AJ | 1 |
Cardozo, L; Kelleher, C; Kobashi, K; Lucente, V | 1 |
Jonas, U; Rackley, RR | 1 |
Simpson, D; Wagstaff, AJ | 1 |
Serels, S | 1 |
Hashim, H | 1 |
Halaska, M; Millard, RJ | 1 |
Payne, CK | 1 |
Hussar, DA | 1 |
MacDiarmid, SA; Staskin, DR | 1 |
Appell, RA; McCrery, RJ; Smith, PP | 1 |
Cardozo, L; Castro-Diaz, D; Gittelman, M; Huang, M; Ridder, A | 1 |
Staskin, DR; Te, AE | 1 |
Sieber, P; Wagg, A; Wyndaele, JJ | 1 |
Goepel, M | 1 |
Colaço, J; Gonçalves, V; Metello, J; Nogueira, B; Retto, H; Torgal, M; Vieira, A | 1 |
Garely, AD; Lucente, V; Smith, N; Vapnek, J | 1 |
16 review(s) available for quinuclidines and Urinary Incontinence
Article | Year |
---|---|
Clinical pharmacokinetics and pharmacodynamics of solifenacin.
Topics: Animals; Clinical Trials as Topic; Humans; Protein Binding; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence | 2009 |
Which anticholinergic drug for overactive bladder symptoms in adults.
Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Comparative Effectiveness Research; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2012 |
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Chronic Disease; Cresols; Drug Combinations; Female; Humans; Imidazoles; Mandelic Acids; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
The emerging role of solifenacin in the treatment of overactive bladder.
Topics: Clinical Trials as Topic; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence | 2004 |
Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine.
Topics: Benzilates; Benzofurans; Clinical Trials as Topic; Duloxetine Hydrochloride; Humans; Muscarinic Antagonists; Nortropanes; Pyrrolidines; Quinuclidines; Selective Serotonin Reuptake Inhibitors; Solifenacin Succinate; Tetrahydroisoquinolines; Thiophenes; Urinary Incontinence | 2004 |
Elevating our therapeutic expectations in overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2004 |
Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
Topics: Adult; Double-Blind Method; Female; Humans; Interpersonal Relations; Male; Multicenter Studies as Topic; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence | 2005 |
Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis.
Topics: Adult; Clinical Trials, Phase III as Topic; Female; Humans; Male; Middle Aged; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence | 2005 |
Solifenacin in the management of the overactive bladder syndrome.
Topics: Clinical Trials as Topic; Humans; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders | 2005 |
Solifenacin in overactive bladder syndrome.
Topics: Humans; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence | 2005 |
Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Placebos; Population; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence | 2006 |
Solifenacin in overactive bladder syndrome.
Topics: Animals; Antimutagenic Agents; Clinical Trials as Topic; Humans; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence | 2006 |
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2006 |
The emergence of new drugs for overactive bladder.
Topics: Acetylcholine; Amines; Animals; Anticonvulsants; Benzhydryl Compounds; Cresols; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Gabapentin; gamma-Aminobutyric Acid; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Product Surveillance, Postmarketing; Quinuclidines; Randomized Controlled Trials as Topic; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 2006 |
Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
Topics: Aged; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Muscarinic Antagonists; Quinuclidines; Randomized Controlled Trials as Topic; Retrospective Studies; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence | 2006 |
16 trial(s) available for quinuclidines and Urinary Incontinence
Article | Year |
---|---|
Phase 1 clinical trial of Vesicare™ (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.
Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Pilot Projects; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quinuclidines; Robotic Surgical Procedures; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence | 2014 |
Effect of electroacupuncture versus pelvic floor muscle training plus solifenacin for moderate and severe mixed urinary incontinence in women: a study protocol.
Topics: Adult; Aged; Clinical Protocols; Electroacupuncture; Exercise Therapy; Female; Humans; Middle Aged; Muscle Strength; Pelvic Floor; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence | 2014 |
A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy.
Topics: Adult; Aged; Double-Blind Method; Humans; Male; Middle Aged; Muscarinic Antagonists; Prostatectomy; Quinuclidines; Robotic Surgical Procedures; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence | 2015 |
The therapeutic effect of solifenacin succinate on the recovery from voiding dysfunction after radical prostatectomy in men with clinically localized prostate cancer: a prospective, randomized, controlled study.
Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Drug Therapy, Combination; Humans; Male; Midodrine; Muscarinic Antagonists; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quinuclidines; Recovery of Function; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence | 2015 |
Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Patient Satisfaction; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Retention | 2008 |
Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Prospective open label study of solifenacin for overactive bladder in children.
Topics: Child; Female; Humans; Male; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Taiwan; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination | 2010 |
Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence | 2004 |
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
Topics: Constipation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2005 |
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.
Topics: Analysis of Variance; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2005 |
Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence.
Topics: Aged; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin.
Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Muscarinic Antagonists; Population; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |
Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
Topics: Adolescent; Adult; Aged; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence; Urodynamics | 2006 |
Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride.
Topics: Aged; Analgesics; Benzilates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Nortropanes; Prospective Studies; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2007 |
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Constipation; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Visual Acuity; Xerostomia | 2007 |
17 other study(ies) available for quinuclidines and Urinary Incontinence
Article | Year |
---|---|
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Humans; Incontinence Pads; Mandelic Acids; Markov Chains; Medication Adherence; Models, Economic; Muscarinic Antagonists; Patient Dropouts; Phenylpropanolamine; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence | 2013 |
Editorial comment.
Topics: Humans; Male; Muscarinic Antagonists; Prostatectomy; Quinuclidines; Robotic Surgical Procedures; Tetrahydroisoquinolines; Urinary Incontinence | 2015 |
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation.
Topics: Benzhydryl Compounds; Computer Simulation; Cost-Benefit Analysis; Cresols; Humans; Italy; Markov Chains; Muscarinic Antagonists; Pharmacogenetics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2009 |
[Solifenacin in treatment of the overactive bladder syndrome--diagnosis, clinical management and results].
Topics: Aged; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Finding unrecognized information in overactive bladder clinical trial data: a new approach to understanding placebo and treatment effects.
Topics: Clinical Trials as Topic; Forecasting; Humans; Logistic Models; Models, Biological; Muscarinic Antagonists; Placebo Effect; Placebos; Quinuclidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sample Size; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2013 |
[In overactive bladder, above all urgency is stressful. The patients know the site of each toilet].
Topics: Cholinergic Antagonists; Humans; Placebos; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Time Factors; Urinary Incontinence; Urination Disorders | 2004 |
[Overactive bladder. New anticholinergic drug controls urinary urge].
Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence; Urodynamics | 2004 |
Solifenacin and darifenacin for overactive bladder.
Topics: Benzofurans; Drug Interactions; Humans; Intestinal Obstruction; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence; Xerostomia | 2005 |
New treatment options for overactive bladder.
Topics: Benzofurans; Clinical Trials as Topic; Humans; Muscarinic Antagonists; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence | 2005 |
Solifenacin and darifenacin for overactive bladder.
Topics: Benzofurans; Drug Interactions; Humans; Muscarinic Antagonists; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence | 2005 |
Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Topics: Animals; Female; Models, Molecular; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Quinuclidines; Radioligand Assay; Rats; Rats, Wistar; Receptor, Muscarinic M3; Saliva; Solifenacin Succinate; Stereoisomerism; Structure-Activity Relationship; Tetrahydroisoquinolines; Urinary Bladder; Urinary Incontinence | 2005 |
Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
Topics: Benzhydryl Compounds; Cresols; Double-Blind Method; Humans; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2006 |
Solifenacin in overactive bladder syndrome: a viewpoint by Scott Serels.
Topics: Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence | 2005 |
Solifenacin in overactive bladder: a viewpoint by Hashim Hashim.
Topics: Animals; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence | 2005 |
New drugs 06, part I.
Topics: Acamprosate; Adenine Nucleotides; Alcohol Deterrents; Amyloid; Analgesics, Non-Narcotic; Anti-HIV Agents; Antifungal Agents; Antineoplastic Agents; Aptamers, Nucleotide; Arabinonucleosides; Azabicyclo Compounds; Benzofurans; Clofarabine; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Exenatide; Fibroblast Growth Factor 7; Guanine; Humans; Hypoglycemic Agents; Islet Amyloid Polypeptide; Lipopeptides; Lipoproteins; Macular Degeneration; Micafungin; omega-Conotoxins; Patient Education as Topic; Peptides; Peptides, Cyclic; Piperazines; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Stomatitis; Taurine; Tetrahydroisoquinolines; Urinary Incontinence; Venoms | 2006 |
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
Topics: Analysis of Variance; Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2006 |